Zobrazeno 1 - 10
of 41
pro vyhledávání: '"L N, Shingarova"'
Autor:
D. A. Dolgikh, L. N. Shingarova, Alexander V. Zlobinov, Rustam H. Ziganshin, Vasiliy A. Mironov, S. Sh. Gapizov, Lada E. Petrovskaya, Mikhail P. Kirpichnikov, G.Y. Lomakina, E. A. Kryukova
Publikováno v:
Applied biochemistry and biotechnology. 193(11)
Overproduction of the membrane proteins in Escherichia coli cells is a common approach to obtain sufficient material for their functional and structural studies. However, the efficiency of this process can be limited by toxic effects which decrease t
Autor:
E. A. Kryukova, S. Sh. Gapizov, M.V. Kryukova, Elizaveta Rivkina, Mikhail P. Kirpichnikov, Dmitry A. Dolgikh, Yana Y. Berlina, Lada E. Petrovskaya, L. N. Shingarova
Publikováno v:
Biomolecules, Vol 11, Iss 1229, p 1229 (2021)
Biomolecules
Volume 11
Issue 8
Biomolecules
Volume 11
Issue 8
A gene coding for a novel putative amylase, oligo-1,6-glucosidase from a psychrotrophic bacterium Exiguobacterium sibiricum from Siberian permafrost soil was cloned and expressed in Escherichia coli. The amino acid sequence of the predicted protein E
Autor:
S. A. Yakimov, S. Sh. Gapizov, D. A. Dolgikh, E. A. Kryukova, Lada E. Petrovskaya, Mikhail P. Kirpichnikov, E. V. Svirshchevskaya, E. P. Lukashev, E. F. Boldyreva, L. N. Shingarova
Publikováno v:
Biotechnology and applied biochemistryReferences. 66(4)
Fusion with an albumin-binding domain (ABD) of streptococcal protein G represents a popular approach for half-life extension of small protein therapeutics in the organism. To increase the circulation time of engineered αvβ3-integrin-binding protein
Autor:
A. V. Alessenko, S. V. Gurianova, L N Shingarova, Sergey O. Bachurin, Y. O. Karatasso, Elena F. Shevtsova
Publikováno v:
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. 9:189-198
Since 1983, Dimebon (Dimebolin) is used clinically in Russia as an antihistamine drug. Recent interest in Dimebolin is associated with its therapeutic effect in patients with Alzheimer’s disease. Animal studies have shown that Dimebon activity is r
Autor:
L N Shingarova, A. V. Alessenko, S. V. Gurianova, Y. O. Karatasso, Elena F. Shevtsova, Sergey O. Bachurin
Publikováno v:
Biomeditsinskaia khimiia. 62(4)
Dimebon (Dimebolin) is an antihistamine drug which has been used in Russia since 1983. Recently Dimebolin has attracted renewed interest after being shown to have positive effects on persons suffering from Alzheimer's disease. Animal studies have sho
Autor:
O. V. Masalova, L. N. Shingarova, Alla A. Kushch, V L Tunitskaia, Burkov An, Ulanova Ti, E. I. Lesnova
Publikováno v:
Molecular Biology. 46:473-480
Hepatitis C is related to the most important socially significant human infectious diseases; however, vaccine against this virus up to now has notbeen created. One of the possible components of vaccine is the nonstructural protein NS3 of hepatitis C
Autor:
Nina V. Tikunova, M. P. Kirpichnikov, L. R. Lebedev, T. A. Batanova, M. A. Vikhrova, Ludmila A. Frank, L. N. Shingarova
Publikováno v:
Russian Journal of Bioorganic Chemistry. 37:298-306
Six unique phage antibodies against human tumor necrosis factor (TNF) were selected from the earlier constructed naive combinatorial library of single-chain antibodies by affinity selection. The TNF binding of these antibodies was examined by enzyme
Autor:
L. N. Shingarova, S. V. Guryanova, S. A. Yakimov, E. F. Boldyreva, Alexei N. Nekrasov, E. A. Kryukova, Mikhail P. Kirpichnikov, D. A. Dolgih, Lada E. Petrovskaya
Publikováno v:
Russian Journal of Bioorganic Chemistry. 36:301-309
The tumor necrosis factor (TNF) is a proinflammatory cytokine that plays a pivotal role in the regulation of the human immune system. Studies of the TNF functional topography are a challenging task in bioengineering. We have produced genes encoding t
Autor:
Tomova As, Alexander L. Gintsburg, Yu. M. Romanova, Anna S. Karyagina, Vladimir G. Lunin, I. P. Lupu, L. N. Shingarova
Publikováno v:
Molecular Genetics, Microbiology and Virology. 23:178-183
The goal of this work was to elucidate the mechanism of the direct interaction of bacteria cells with tumor necrosis factor (TNF-α, cytokine). It was shown previously that this interaction facilitated the activation of the bacterial growth and recul
Autor:
Lev S. Sandakhchiev, Oksana V. Nekrasova, T. K. Aliev, Nina V. Tikunova, T. A. Batanova, A. A. Panina, L. N. Shingarova, E. F. Boldyreva, A. A. Chepurnov, V. A. Toporova, T. E. Yun, Kirpichnikov Mp
Publikováno v:
Scopus-Elsevier
A full-size human antibody to Ebola virus was constructed by joining genes encoding the constant domains of the heavy and light chains of human immunoglobulin with the corresponding DNA fragments encoding variable domains of the single-chain antibody